Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia

Leukemia

Volumn 13, Issue 7, 1999, Pages 991-998

  Guyotat, D ^a   Wahbi, K ^b   Viallet, A ^a   Piselli, S ^a   Campos, L ^a,c  

^a UNIVERSITÉ JEAN MONNET   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

BCR ABL gene; Chronic myeloid leukemia; Hematopoietic stem cell; Long term culture; NOD SCID mouse

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CD34 ANTIGEN; CD38 ANTIGEN; FLUOROURACIL; HLA DR ANTIGEN; INTERLEUKIN 3; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; CELL CULTURE; CELL SELECTION; CELL TRANSPLANTATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE;

EID: 0032776119     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401456     Document Type: Article

References (35)

1. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63: 125-130.
2. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497.
3. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-291.
4. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Engl J Med 1988; 319: 990-998.
5. Kantarjian HM, O'Brien S, Anderlini P, Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069-3081.
6. Bhatia R, Verfaillie CM, Miller JS, McGlave P. Autologous transplantation therapy for chronic myelogenous leukemia. Blood 1997; 89: 2623-2634.
7. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 1991; 114: 532-538.
8. McGlave PB, De Fabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J, Simonsson B, Carella C, Aepli D. Autologous transplant for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 1994; 343: 1486-1488.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
10. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New Engl Med 1983; 308: 1493-1498.
11. Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V. In vitro purging in chronic myelogenous leukemia. Effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 1991; 8: 265-273.
12. Jazwiec B, Mahon F-X, Pigneux A, Pigeonnier V, Reiffers J. 5-Fluorouacil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells. Exp Hematol 1995; 23: 1509-1514.
13. McGlave PB, Arthur D, Miller WJ, Lasky L, Kersey J. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma. Bone Marrow Transplant 1990; 6: 115-122.
14. Calabretta B, Skorsky T, Ratajczak MZ, Gewirtz AM. Antisense strategies in the treatment of leukemias. Semin Oncol 1996; 23: 78-87.
15. Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK. Klingeman HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Spinelli JG, Sutherland HJ, Eaves AC. Autografting with cultured marrow in chronic myelogenous leukemia: results of a pilot study. Blood 1994; 84: 724-732.
16. Chalmers EA, Franklin IM, Kelsey SM, Newland AC, Clark RE, Sproul AM, Crotty G, McCann SR, Feilding A, Goldstone AH, Hepplestone A, Watson W, Sharp RA, Tansey P. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cells. Br J Haematol 1997; 96: 627-634.
17. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podesta M, Celesti L, Chimirri F, Abote M, Vassallo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti AM, van den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.
18. Carella AM, Lerma E, Celesti L, Dejana A, Panagiotis A, Corsetti MT, Frassoni F, Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen. Br J Haematol 1998; 100: 445-448.
19. Fisher T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML. Bone Marrow Transplant 1998; 21: 1029-1036.
20. Heinzinger M, Waller CF, Rosenstiel A, Scheid S, Burger KJ, Lange W. Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Leukemia 1998; 12: 333-339.
21. Kirk JA, Reems JA, Roecklein BA, Van Devanter DR, Bryant EM, Radich J, Edmands S. Lee A. Torok-Storb B. Benign marrow progenitors are enriched in the CD34+/HLA-DRIo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood 1995; 86: 737-743.
22. Verfaillie CM, Bathia R, Miller W, Mortari F, Roy V, Burger S, McCullough J. Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood 1996; 87: 4770-4779.
23. Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 1996; 88: 2162-2171.
24. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 1992; 80: 2522-2530.
25. Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 1993; 81: 801-807.
26. Maguer-Satta V. Petzer AL, Eaves AC, Eaves CJ, BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia. Blood 1996; 88: 1796-1804.
27. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104-108.
28. Milteny S, Muller W, Weichel W, Radbruch A. High grade magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
29. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay, Leukemia 1994; 8: 1095-1104.
30. Bertolini F, Battaglia M, Lanza A, Gibelli N, Palermo B, Pavesi L, Caprotti M, Robustelli della Cuna G. Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors. Blood 1997; 90: 3027-3036.
31. Bedi A, Zehnbauer BA, Collector Ml, Barber JP, Zicha MS, Sharkis SJ, Jones RJ. Bcr-Abl gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 1993; 81: 2898-2902.
32. + cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood 1994; 83: 1744-1749.
33. Thijsen SFT, Schuurhuis CJ, van Oostveen JW, Theijsmeijer AP, Langenhuijsen MMAC, Ossenkoppele GJ. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR. Leukemia 1997; 11: 301-305.
34. Savoldo B, Sammarelli G, Dotti G, Garau D, Regazzi E, Cilloni D, Tabilio A, Rizzoli V, Carlo-Stella C. Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells. Leukemia 1998; 12: 434-440.
35. Petzer AL, Eaves CJ, Barnett MJ, Eaves AC. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 1997; 90: 64-69.